Published online Jul 28, 2022. doi: 10.4329/wjr.v14.i7.238
Peer-review started: February 14, 2022
First decision: April 8, 2022
Revised: May 6, 2022
Accepted: July 5, 2022
Article in press: July 5, 2022
Published online: July 28, 2022
Processing time: 162 Days and 12.4 Hours
The background behind this literature is the initial collaboration between SPS and MMK who explored the effects of renal afferent denervation from a basic science perspective. Of note, MMK has contributed to a number of early literatures regarding renal sympathetic denervation.
The utilization of thermal radiofrequency ablation in medical practice has grown tremendously over the past decade alone. We are motivated to contribute to the potential direction of bringing this therapeutic modality to greater avenues of evaluation compared to the past. Of note, renal sympathetic denervation (RSD) is not used in the United States yet.
The objective was to utilize current peer-reviewed case report data to gain a current understanding of the climate regarding RSD interventions.
Systematic Review of the literature.
RSD intervention has shown, in these case reports, to mainly lower office systolic blood pressure and lessen the patient burden on medication regimens.
The promising results of RSD can simplify therapeutic regimens in patients with resistant hypertension. There is a significant amount of area which can be explored in clinical trials in the future.
The study team believes this therapeutic intervention needs to be brought under greater attention among the interventional radiology community for it future usage.